Update on C-Cell Neuroendocrine Neoplasm: Prognostic and Predictive Histopathologic and Molecular Features of Medullary Thyroid Carcinoma Chan Kwon JungShipra AgarwalOzgur Mete ReviewPaper 08 March 2023 Pages: 1 - 22
The Impact of the 2022 WHO Classification of Thyroid Neoplasms on Everyday Practice of Cytopathology Esther Diana RossiZubair Baloch ReviewPaper 17 February 2023 Pages: 23 - 33
High-Grade Non-Anaplastic Thyroid Carcinomas of Follicular Cell Origin: A Review of Poorly Differentiated and High-Grade Differentiated Carcinomas Vincent CracoliciNicole A. Cipriani ReviewPaper 24 January 2023 Pages: 34 - 47
The Thyroid Pathologist Meets Therapeutic Pharmacology Christopher M. SandeIsabella Tondi RestaVirginia A. Livolsi ReviewPaper 01 February 2023 Pages: 48 - 56
The Spectrum of Familial Pituitary Neuroendocrine Tumors Eleni ArmeniAshley Grossman ReviewPaper 18 November 2022 Pages: 57 - 78
Diagnostic, Prognostic, and Predictive Role of Ki67 Proliferative Index in Neuroendocrine and Endocrine Neoplasms: Past, Present, and Future Stefano La Rosa ReviewPaper Open access 17 February 2023 Pages: 79 - 97
Sclerosing Mucoepidermoid Carcinoma with Eosinophilia of the Thyroid and Mucoepidermoid Carcinoma of the Thyroid: What’s in a Name? Virginia A. LiVolsi Letter 09 February 2023 Pages: 98 - 99
Primary Thyroid Mucoepidermoid Carcinoma (MEC) Is Clinically, Prognostically, and Molecularly Different from Sclerosing MEC with Eosinophilia: A Multicenter and Integrated Study Hieu Trong LeTruong P. X. NguyenHuy Gia Vuong OriginalPaper 17 November 2022 Pages: 100 - 111
The Presence of Typical “BRAFV600E-Like” Atypia in Papillary Thyroid Carcinoma is Highly Specific for the Presence of the BRAFV600E Mutation John TurchiniLoretta SiosonAnthony J. Gill OriginalPaper 28 January 2023 Pages: 112 - 118
The Significance of Unsampled Microscopic Thyroid Carcinomas in Multinodular Goiter Orhan SemerciHasan Gucer OriginalPaper 17 December 2022 Pages: 119 - 128
TOP2A Expression in Pheochromocytoma and Abdominal Paraganglioma: a Marker of Poor Clinical Outcome? Karolina Solhusløkk HöseAdam StenmanC. Christofer Juhlin OriginalPaper Open access 19 January 2023 Pages: 129 - 141
Infiltrative Growth Predicts the Risk of Recurrence After Surgery in Well-Differentiated Non-Functioning Pancreatic Neuroendocrine Tumors Marco Schiavo LenaStefano PartelliClaudio Doglioni OriginalPaper 24 December 2022 Pages: 142 - 155
Menin Loss in Pheochromocytoma of Multiple Endocrine Neoplasia Type 1 Sylvia L. AsaAmr Mohamed OriginalPaper 15 December 2022 Pages: 156 - 158
Thyroblastoma—a Primitive Multilineage Thyroid Neoplasm with Somatic DICER1 Alteration Lori A. EricksonMichael RiveraSounak Gupta Letter 15 February 2023 Pages: 159 - 160
Sarcomatous Transformation of a Medically Treated Lactotroph Pituitary Neuroendocrine Tumor? Merryl TerryGerald ReisArie Perry OriginalPaper Open access 24 February 2023 Pages: 161 - 163